DrugId:  1
1. Name:  Meningococcal Polysaccharide Vaccine Group W-135
2. Groups:  Approved, Experimental, Investigational
3. Description:  Meningococcal group W-135 polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup W-135. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup W-135.
4. Indication:  Not Available
DrugId:  2
1. Name:  Meningococcal Polysaccharide Vaccine Group Y
2. Groups:  Approved, Experimental, Investigational
3. Description:  Meningococcal group Y polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup Y. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup Y.
4. Indication:  Not Available
DrugId:  3
1. Name:  Meningococcal group A polysaccharide
2. Groups:  Approved, Experimental, Investigational
3. Description:  Meningococcal group A polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup A. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup A.
4. Indication:  Not Available
DrugId:  4
1. Name:  Meningococcal group C polysaccharide
2. Groups:  Approved, Experimental, Investigational
3. Description:  Meningococcal group C polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup C. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup C.
4. Indication:  Not Available
